Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs
ICD-10 R87.2 is a billable code used to indicate a diagnosis of abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs.
R87.2 refers to the abnormal levels of drugs, medicaments, and biological substances found in specimens taken from female genital organs. This can include abnormal findings in urine, vaginal swabs, or other specimens that indicate the presence of substances not typically expected in these samples. Such abnormalities may arise from various factors, including medication use, exposure to environmental toxins, or underlying medical conditions. Clinicians may encounter this code when evaluating patients for potential drug interactions, side effects, or complications related to pharmacological treatments. The identification of abnormal levels can lead to further diagnostic testing and management strategies tailored to the patient's specific needs, ensuring that any underlying issues are addressed appropriately.
Detailed patient history, including medication use and any relevant symptoms.
Patients presenting with unexplained symptoms potentially related to drug levels.
Consideration of polypharmacy and its effects on lab results.
Acute care notes detailing the patient's presentation and any immediate interventions.
Patients with acute symptoms potentially linked to drug toxicity.
Rapid assessment of lab results and correlation with clinical findings.
Used to assess overall health and detect abnormalities in drug levels.
Document the reason for testing and any relevant patient history.
Internal medicine may require more detailed documentation of medication history.
Documentation should include the specific substances tested, their levels, the clinical context, and any relevant patient history that may explain the abnormal findings.
